Feature Pharnext platform taps genomic data, AI for new combination medicines By Melane Sampson A new drug discovery paradigm, PLEOTHERAPY, developed by Pharnext SA (FR0011191287-ALPHA) is based on big genomic data, artificial intelligence, and rigorous experimental analysis that involves... August 14, 2018